New diabetes medical devices for more efficient healthcare

Cases of diabetes are rising, especially in children. Companies like Rimidi, ARKRAY & Labcorp are developing new medical devices to help patients

Diabetes is the most expensive chronic condition to manage and is one of the top causes of death in the US today. As a result, healthcare businesses are innovating affordable medical devices to support patients.

Rimidi and ARKRAY providing affordable healthcare for diabetes patients 

Clinical management platform Rimidi has just entered into a new partnership with ARKRAY, a leader of diabetes care. ARKRAY’s GLUCOCARD® Shine Connex Blood Glucose Monitoring System is now integrated with the Rimidi Platform, allowing for blood glucose data to be more accessible for providers and patients.

“At ARKRAY, we’re focused on providing patients with the best tools and resources possible to properly manage their diabetes,” said Robert Wernsman, Vice President of Consumer Health at ARKRAY. “We’re proud to offer affordable, reliable blood glucose metres that enable greater testing frequency for patients living with diabetes and are excited to partner with Rimidi to empower providers with the ability to remotely monitor their patients and drive proper actionable insights within their workflow.”

“With a large portion of the U.S. population living with diabetes, and a significant amount living in areas with poor cellular service, patients need devices that they can rely on to monitor their conditions without having to schedule an in-person appointment with their provider,” said Lucienne Ide, MD, PhD, Founder and CEO of Rimidi. “Through our partnership with ARKRAY, we’re tackling these challenges head on, ensuring more patients and providers have the tools they need to properly monitor conditions and make actionable insights that improve health outcomes.”

 

Labcorp helps diabetes patients understand their health status

Labcorp has launched the Labcorp OnDemand test, which measures hemoglobin A1c (HbA1c) from a blood sample and will help those at-risk of diabetes find out if they are at risk of developing diabetes. The device divides plasma and red blood cells, to allow a more detailed analysis of the sample. 

“Diabetes is a serious disease affecting millions of people in the United States,” said Dr. Brian Caveney, chief medical officer and president at Labcorp Diagnostics. “Our Labcorp OnDemand Diabetes Risk Test at-home collection kit now makes it easier for consumers to understand their diabetes risk and health status using an innovative and approved collection device. This test offers a convenient way for more people to manage their health and stay informed, so they can seek treatment that may lead to better health outcomes.”

Share

Featured Articles

Healthcare staff shortage creates cyber security risk

The healthcare industry is chronically understaffed which is exacerbating cyber security risk, says SailPoint’s Steve Bradford, in new research report

Philip Morris International (PMI) in agreement with KT&G

PMI and KT&G are building a smoke-free world. In a new agreement between the two companies, smoke-free alternatives are within reach for smokers

Health tech leader Philips shares sustainability ambition

Roy Jakobs, Royal Philips CEO, says the health technology company’s sustainability impact plan will ‘enhance accountability & strengthen talent’

Automating gene therapy & pharma discovery at Automata

Medical Devices & Pharma

Itai Hayut, CEO of Scopio Labs, on AI & blood cancer

Technology & AI

2023 predictions with Harshit Jain, global CEO of Doceree

Telehealth & COVID-19